CSPC Pharmaceutical Group... (CHJTF)

PNK: CHJTF · Real-Time Price · USD

0.64

0.02 (3.23%)

At close: May 01, 2025, 8:00 PM

CSPC Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q3 2018	Q2 2018	Q4 2017	Q2 2017	Q1 2017	Q4 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	6.78B	9B	13.23B	10.47B	11.56B	10.62B	11.36B	9.72B	8.65B	6.59B	4.82B	4.6B	4.33B	n/a	3.72B	4.38B	2.71B	n/a	2.9B	1.86B	n/a
Short-Term Investments	1.47B	2.62B	1.19B	1.63B	4.01B	5.09B	1.77B	3.59B	1.82B	1.68B	2.06B	1.55B	2.29B	n/a	2.63B	1.1B	527.78K	n/a	466.5K	10.45M	n/a
Long-Term Investments	4.8B	6.93B	5.13B	3.03B	4.25B	3.93B	4.42B	4.24B	4.66B	3.14B	1.83B	1.27B	-1.39B	n/a	-2.02B	-743.52M	270.75M	n/a	153.38M	15.26M	n/a
Other Long-Term Assets	1.53B	1.12B	245.79M	2.25B	630.6M	646.66M	513.63M	237.43M	421.34M	-164.32M	172.73M	125.16M	2.62B	n/a	2.63B	1.1B	527.78K	n/a	466.51K	75.78M	n/a
Receivables	9.94B	12.3B	10.68B	9.48B	7.62B	7.01B	7.98B	6.93B	5.38B	6.22B	4.92B	5.12B	13.14M	n/a	1.00	2.24B	n/a	n/a	2.77B	3.51B	n/a
Inventory	3.13B	3.72B	3.46B	2.75B	2.87B	3.08B	3.03B	2.2B	2.21B	2.42B	2.84B	2.81B	3.04B	n/a	2.73B	2.42B	2.2B	n/a	1.73B	1.67B	n/a
Other Current Assets	362.35M	798.3M	10.51B	9.54B	6.84B	6.23B	6.55B	5.8B	415.06M	5.91B	4.64B	5.18B	4.11B	n/a	4.65B	3.48B	3.55B	n/a	337.53M	302.72M	n/a
Total Current Assets	21.89B	28.44B	29.45B	24.38B	26.9B	26.76B	24.88B	22.98B	18.88B	18.07B	15.32B	14.83B	13.78B	4.96B	13.72B	11.39B	8.47B	3.24B	7.55B	6.92B	2.3B
Property-Plant & Equipment	13.08B	12.5B	13.5B	11.36B	12.32B	11.81B	11.7B	11.02B	10.59B	9.99B	10.38B	9.75B	7.2B	n/a	6.64B	6.05B	5.54B	n/a	5.32B	4.89B	n/a
Goodwill & Intangibles	2.84B	2.47B	2.43B	2.5B	2.67B	2.24B	939.25M	912.58M	958.84M	886.03M	1.69B	1.65B	945.86M	n/a	855.71M	187.94M	224.19M	n/a	171.04M	179.66M	n/a
Total Long-Term Assets	22.5B	23.03B	21.51B	19.29B	20B	18.77B	17.62B	16.51B	16.78B	13.89B	14.12B	12.84B	9.39B	n/a	8.13B	6.61B	6.05B	n/a	5.67B	5.19B	n/a
Total Assets	44.39B	51.47B	50.96B	43.67B	46.9B	45.53B	42.5B	39.48B	35.65B	31.96B	29.44B	27.66B	22.69B	n/a	21.85B	18B	14.52B	n/a	13.22B	12.04B	n/a
Account Payables	2.61B	3.18B	2.84B	2.36B	2.01B	1.79B	1.62B	1.48B	1.24B	1.57B	1.43B	2.28B	3.27B	n/a	6.35B	1.3B	1.55B	n/a	1.09B	1.13B	n/a
Deferred Revenue	n/a	n/a	359.15M	251.91M	897.58M	299M	524.05M	395.42M	741.85M	216.47M	563.5M	338.11M	2.00	n/a	1.00	1.69B	1.00	n/a	1.00	2.00	n/a
Short-Term Debt	392.2M	217.66M	450.22M	55.37M	331.83M	384.58M	n/a	n/a	99M	99M	23M	60M	70.59M	n/a	743.14M	927.28M	833.94M	n/a	897.78M	939.19M	n/a
Other Current Liabilities	945.86M	7.39B	1.52B	233.51M	1.86B	1.71B	2.26B	1.73B	1.92B	953.29M	1.45B	1.57B	4.91B	n/a	1.53B	2.59B	1.97B	n/a	2.1B	2.32B	n/a
Total Current Liabilities	9.63B	11.21B	11.21B	9.03B	10.06B	9.92B	8.84B	8.32B	7.47B	8.66B	6.98B	6.98B	7.23B	n/a	7.28B	4.81B	4.35B	n/a	3.66B	3.76B	n/a
Long-Term Debt	n/a	n/a	n/a	19.9M	28.95M	11.79M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.09M	50M	217.89M	n/a	215.24M	406.11M	n/a
Other Long-Term Liabilities	407.81M	991.13M	134.01M	372.32M	110.34M	408.61M	97.59M	330.79M	76.73M	38.43M	62.39M	67.93M	201.9M	n/a	513.27M	153.71M	155.16M	n/a	156.66M	151.84M	n/a
Total Long-Term Liabilities	888.67M	1.06B	815.91M	1.14B	1.01B	1.13B	534.69M	750.51M	490.05M	440.33M	457.11M	534.09M	439.35M	n/a	475.81M	313.68M	479.15M	n/a	433.56M	628.18M	n/a
Total Liabilities	10.52B	12.28B	12.03B	10.16B	11.07B	11.05B	9.37B	9.07B	7.96B	9.1B	7.43B	7.52B	7.67B	n/a	7.75B	5.13B	4.83B	n/a	4.09B	4.38B	n/a
Total Debt	507.33M	417.85M	778.3M	415.26M	654.05M	800.09M	115.04M	185.7M	375.51M	317.01M	209.78M	297.88M	70.45M	n/a	793.23M	824.82M	942.99M	n/a	1.02B	1.35B	n/a
Common Stock	11.03B	11.83B	12B	10.9B	12.24B	12.78B	13.33B	13.1B	12.92B	11.94B	12.19B	12.4B	11.35B	n/a	10.91B	10.8B	9.2B	n/a	9.46B	8.41B	n/a
Retained Earnings	23.34B	29.3B	24.03B	22.86B	23.73B	22.49B	21.13B	18.87B	15.79B	11.9B	10.86B	8.57B	n/a	n/a	n/a	n/a	5.62B	n/a	5.27B	4.23B	n/a
Comprehensive Income	n/a	-3.55B	-1.56B	-1.73B	-1.97B	-2.3B	-2.57B	-2.4B	-2.12B	-1.86B	-2.28B	-2.11B	-2.8B	n/a	n/a	-2.3B	n/a	n/a	-1.88B	n/a	n/a
Shareholders Equity	32.26B	37.45B	36.56B	31.82B	33.9B	32.87B	31.79B	29.45B	26.48B	21.88B	20.65B	18.74B	15.02B	n/a	13.61B	12.8B	9.61B	n/a	9.05B	7.66B	n/a
Total Investments	6.27B	9.55B	6.31B	4.66B	8.26B	9.02B	6.18B	7.82B	6.48B	4.83B	3.89B	2.81B	896.76M	n/a	614.49M	356.57M	271.28M	n/a	153.85M	25.71M	n/a